European Archives - Page 734 of 1116 - European Medical Journal

Cancer Treatment Response Could be Predicted by Tumour Mutations

TUMOUR mutations could be used to predict patients’ responses to cancer treatment drugs, according to the results of a recent study…

Review of the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2019

Profs Dominique Valla and Tom Hemming Karlsen welcomed the approximately 9,000 delegates from 125 countries, with the former offering some sound advice…

The Role of Adipose Tissue in Metabolic and Cardiovascular Complications After Liver Transplantation

Metabolic and cardiovascular complications are an important burden in patients after liver transplantation (LT) for many reasons, including as a result…

ILC 2019 Interview: Professor Dina Tiniakos

We met with EMJ Hepatology Editorial Board member, Prof Dina Tiniakos, at the ILC, to discuss her career path and her experience at the congress…

Editor's Pick: Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease

This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…

Efficacy of Oral Thrombopoietin Receptor Agonist Lusutrombopag in Chronic Liver Disease by Underlying Disease Aetiology

Among patients with chronic liver disease (CLD), thrombocytopenia (TCP) is a frequent complication.1,2 Before invasive procedures and surgery in CLD…

Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…

Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy

The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…

A Comparison of Currently Available Direct-Acting Antiviral Hepatitis C Virus Therapy in Canada: On the Path to Elimination

As many as 250,000 Canadians are living with hepatitis C virus (HCV) infection,1 and specific populations, such as people who use drugs (PWUD)…

The NIACE Score: A Prognostic Indicator in Hepatocellular Carcinoma

The NIACE score is an easy-to-calculate prognostic score, and this study demonstrated that NIACE can distinguish between two subgroups with different…